Ahmed Zavier Shawkat, Joad Sabaa, Singh Manpreet, Bandagi Sabiha S
Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Jamaica, NY, U.S.A.
Department of Rheumatology, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Jamaica, NY, U.S.A.
Am J Case Rep. 2014 Mar 1;15:94-6. doi: 10.12659/AJCR.890074. eCollection 2014.
Female, 51 FINAL DIAGNOSIS: Interstitial Granulomatous Dermatitis Symptoms: Joint pain • pruritic rush
Etanercept Clinical Procedure: - Specialty: Rheumatology.
Rare disease.
Interstitial granulomatous disease (IGD) is a rare skin condition that presents with erythematous and violaceous plaques, and may be associated with pruritus and pain. The cause remains unknown, but is often associated with autoimmune disease and drug-related adverse effects. It is diagnosed via biopsy, and the treatment remains unclear.
We report a case of biopsy-proven IGD associated with rheumatoid arthritis that was treated successfully with etanercept therapy.
We emphasize that anti-TNF antibodies may be clinically effective for the treatment of IGD.
女性,51岁 最终诊断:间质性肉芽肿性皮炎 症状:关节疼痛•瘙痒性皮疹 用药:依那西普 临床程序: - 专业:风湿病学。 目的:罕见病。 背景:间质性肉芽肿病(IGD)是一种罕见的皮肤病,表现为红斑和紫红色斑块,可能伴有瘙痒和疼痛。病因尚不清楚,但常与自身免疫性疾病和药物相关不良反应有关。通过活检进行诊断,治疗方法仍不明确。 病例报告:我们报告一例经活检证实与类风湿性关节炎相关的IGD,经依那西普治疗成功。 结论:我们强调抗TNF抗体可能对IGD的治疗具有临床疗效。